Regulation of epithelial cell migration and tumor formation by β-catenin signaling

Experimental Cell Research

Volumn 280, Issue 1, 2002, Pages 119-133

  Müller, Thomas ^a   Bain, Gerard ^a   Wang, Xin ^a,b   Papkoff, Jackie ^a,c  

^a Cambridge Genomics Center   (United States)

^b BIOGEN   (United States)

^c diaDexus Inc   (United States)

Author keywords

Cell migration; Epidermal growth factor; Growth factor; Hepatocyte growth factor scatter factor; Lymphoid enhancer factor 1; Motility; Receptor tyrosine kinase; T cell factor; Tumorigenesis; catenin signaling

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; OSTEOPONTIN; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; GENE TARGETING; HUMAN; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; XENOGRAFT;

MUS MUSCULUS;

EID: 0036033239     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5630     Document Type: Article

References (95)

1. Yap, A. S., Brieher, W. M., and Gumbiner, B. M. (1997). Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol. 13, 119-146.
2. Ozawa, M., Baribault, H., and Kemler, R. (1989). The cytoplasmic domain of the cell adhesion molecule Uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8, 1711-1718.
3. Rimm, D. L., Koslov, E. R., Kebriael, P., Cianci, C. D., and Morrow, J. S. (1995). α(1)(E)-catenin is an actin-binding and actin-bundling protein mediating the attachment of f-actin to the membrane adhesion complex. Proc. Natl. Acad. Sci. USA 92, 8813-8817.
4. Knudsen, K. A., Soler, A. P., Johnson, K. R., and Wheelock, M. J. (1995). Interaction of α-actinin with the cadherin catenin cell-cell adhesion complex via α-catenin. J. Cell Biol. 130, 67-77.
5. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
6. Peifer, M., and Polakis, P. (2000). Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus. Science 287, 1606-1609.
7. Papkoff, J., Rubinfeld, B., Schryver, B., and Polakis, P. (1996). Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol. 16, 2128-2134.
8. Molenaar, M., Vandewetering, M., Oosterwegel, M., Petersonmaduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996). Xtcf-3 transcription factor mediates β-catenin-induced axis formation in xenopus embryos. Cell 86, 391-399.
9. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., and Kemler, R. (1996). Nuclear-localization of β-catenin by interaction with transcription factor LEF-1. Mech. Develop. 59, 3-10.
10. Behrens, J., Vonkries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642.
11. Kennerdell, J. R., and Carthew, R. W. (1998). Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95, 1017-1026.
12. Bhanot, P., Fish, M., Jemison, J. A., Nusse, R., Nathans, J., and Cadigan, K. M. (1999). Frizzled and Dfrizzled-2 function as redundant receptors for Wingless during Drosophila embryonic development. Development 126, 4175-4186.
13. Müller, H., Samanta, R., and Wieschaus, E. (1999). Wingless signaling in the Drosophila embryo: Zygotic requirements and the role of the frizzled genes. Development 126, 577-586.
14. Tsuda, M., Kamimura, K., Nakato, H., Archer, M., Staatz, W., Fox, B., Humphrey, M., Olson, S., Futch, T., Kaluza, V., Siegfried, E., Stam, L., and Selleck, S. B. (1999). The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 400, 276-280.
15. Lin, X., and Perrimon, N. (1999). Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature 400, 281-284.
16. Dominguez, I., and Green, J. B. (2001). Missing links in GSK3 regulation. Dev. Biol. 235, 303-313.
17. Bienz, M. (1999). APC: The plot thickens. Curr. Opin. Genet. Dev. 9, 595-603.
18. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta- dependent phosphorylation of beta-catenin. EMBO J. 17, 1371-1384.
19. Behrens, J., Jerchow, B. A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D., and Birchmeier, W. (1998). Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280, 596-599.
20. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997). β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804.
21. Müller, T., Choidas, A., Reichmann, E., and Ullrich, A. (1999). Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 275, 10173-10183.
22. Papkoff, J., and Aikawa, M. (1998). WNT-1 and HGF regulate GSK3 β activity and β-catenin signaling in mammary epithelial cells. Biochem. Biophys. Res. Commun. 247, 851-858.
23. Marrs, J. A., and Nelson, W. J. (1996). Cadherin cell-adhesion molecules in differentiation and embryogenesis. Int. Rev. Cytol. 165, 159-205.
24. Huber, O., Bierkamp, C., and Kemler, R. (1996). Cadherins and catenins in development. Curr. Opin. Cell Biol. 8, 685-691.
25. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., and Höfler, H. (1994). E-cadherin mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54, 3845-3852.
26. Boyer, B., Valles, A. M., and Edme, N. (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60, 1091-1099.
27. Schmitz, A. A., Govek, E. E., Bottner, B., and Van Aelst, L. (2000). Rho GTPases: Signaling, migration, and invasion. Exp. Cell Res. 261, 1-12.
28. Birchmeier, W., Hülsken, J., and Behrens, J. (1995). E-cadherin as an invasion suppressor. Ciba F. Symp. 189, 124-141.
29. Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Vanroy, F., Mareèl, M. M., and Birchmeier, W. (1993). Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J. Cell Biol. 120, 757-766.
30. Hamaguchi, M., Matsuyoshi, N., Ohnishi, Y., Gotoh, B., Takeichi, M., and Nagai, Y. (1993). p60(v-src) causes tyrosine phosphorylation and inactivation of the N-cadherin catenin cell-adhesion system. EMBO J. 12, 307-314.
31. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitamura, N., Takeichi, M., and Ito, F. (1994). Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes. Commun. 1, 295-305.
32. Piedra, J., Martinez, D., Castano, J., Miravet, S., Dunach, M., and de Herreros, A. G. (2001). Regulation of β-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276, 20436-20443.
33. Hoschuetzky, H., Aberle, H., and Kemler, R. (1994). β-catenin mediates the interaction of the cadherin catenin complex with epidermal growth-factor receptor. J. Cell Biol. 127, 1375-1380.
34. Ochiai, A., Akimoto, S., Kanai, Y., Shibata, T., Oyama, T., and Hirohashi, S. (1994). C-erbB-2 gene-product associates with catenins in human cancer-cells. Biochem. Biophys. Res. Commun. 205, 73-78.
35. Brady-Kalnay, S. M., Rimm, D. L., and Tonks, N. K. (1995). Receptor protein-tyrosine-phosphatase PTP-μ associates with cadherins and catenins in-vivo. J. Cell Biol. 130, 977-986.
36. Fuchs, M., Müller, T., Lerch, M. M., and Ullrich, A. (1996). Association of human protein-tyrosine phosphatase κ with members of the armadillo family. J. Biol. Chem. 271, 16712-17719.
37. Bienz, M., and Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell 103, 311-320.
38. Kinzler, K. W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
39. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, J., Taneyhill, L. A., Deuel, B., Lew, M., Watanabe, C., Cohen, R. L., Melhem, M. F., Finley, G. G., Quirke, P., Goddard, A. D., Hillan, K. J., Gurney, A. L., Botstein, D., and Levine, A. J. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95, 14717-14722.
40. Tetsu, O., and McCormick, F. (1999). β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
41. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998). Identification of c-MYC as a target of the APC pathway [see comments]. Science 281, 1509-1512.
42. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24, 245-250.
43. Liu, W., Dong, X., Mai, M., Seelan, R. S., Taniguchi, K., Krishnadath, K. K., Halling, K. C., Cunningham, J. M., Boardman, L. A., Qian, C., Christensen, E., Schmidt, S. S., Roche, P. C., Smith, D. I., and Thibodeau, S. N. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 26, 146-147.
44. Ilyas, M., Tomlinson, I., Rowan, A., Pignatelli, M., and Bodmer, W. (1997). β-catenin mutations in cell-lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA 94, 10330-10334.
45. Morin, P., Sparks, A., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. (1997). Activation of β-catenin/TCF signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790.
46. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. (1997). Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792.
47. Toyoshima, K., Ito, N., Hiasa, Y., Kamamoto, Y., and Makiura, S. (1971). Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: Establishment of cell line, Nara Bladder Tumor II. J. Natl. Cancer Inst. 47, 979-985.
48. Littlewood, T., Hancock, D., Danielian, P., Parker, M., and Evan, G. (1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690.
49. Weng, Z., Xin, M., Pablo, L., Grueneberg, D., Hagel, M., Bain, G., Müller, T., and Papkoff, J. (2001). Protection against anoikis and downregulation of cadherin expression by a regulatable β-catenin protein. J. Biol. Chem. 277, 18677-18686.
50. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993). Production of high-titer helperfree retrovirus by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
51. Heylen, N., Baurain, R., Remacle, C., and Trouet, A. (1998). Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro. Clin. Exp. Metastasis 16, 193-203.
52. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245.
53. Parish, C. R., Jakobsen, K. B., and Coombe, D. R. (1992). A basement-membrane permeability assay which correlates with the metastatic potential of tumour cells. Int. J. Cancer 52, 378-383.
54. Ducy, P., and Karsenty, G. (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15, 1858-1869.
55. Manske, M., and Bade, E. G. (1994). Growth factor-induced cell-migration: Biology and methods of analysis. Int. Rev. Cytol. 155, 49-96.
56. Valles, A. M., Boyer, B., Badet, J., Tucker, G. C., Barritault, D., and Thiery, J. P. (1990). Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA 87, 1124-1128.
57. Tchao, R. (1982). Novel forms of epithelial cell motility on collagen and on glass surfaces. Cell Motil. 4, 333-341.
58. Geimer, P., and Bade, E. G. (1991). The epidermal growth factor-induced migration of rat liver epithelial cells is associated with a transient inhibition of DNA synthesis. J. Cell Sci. 100, 349-355.
59. Müller, T., Geimer, P., and Bade, E. G. (1993). The growth factor-induced migration of epithelial cells is associated with a transient inhibition of DNA synthesis and a downregulation of PCNA RNA. Eur. J. Cell Biol. 60, 123.
60. Plopper, G. E., Domanico, S. Z., Cirulli, V., Kiosses, W. B., and Quaranta, V. (1998). Migration of breast epithelial cells on Laminin-5: Differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51, 57-69.
61. Bedard, J., May, S., Barbeau, D., Yuen, L., Rando, R., and Bowlin, T. (1999). A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Antiviral Res. 41, 35-43.
62. 3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Methods 187, 85-93.
63. Kolligs, F. T., Hu, G., Dang, C. V., and Fearon, E. R. (1999). Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706.
64. Mattioni, T., Louvion, J., and Picard, D. (1994). Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol. 43, 335-352.
65. −/− colon carcinoma. Science 275, 1784-1787.
66. Nagai, S., Hashimoto, S., Yamashita, T., Toyoda, N., Satoh, T., Suzuki, T., and Matsushima, K. (2001). Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. Int. Immunol. 13, 367-376.
67. Medico, E., Gentile, A., Lo Celso, C., Williams, T., Gambarotta, G., Trusolino, L., and Comoglio, P. (2001). Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Res. 61, 5861-5868.
68. Tuck, A., Elliott, B., Hota, C., Trembaly, E., and Chambers, A. (2000). Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J. Cell. Biochem. 78, 465-475.
69. El-Tanani, M., Barraclough, R., Wilkinson, M. C., and Rudland, P. S. (2001). Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. Cancer Res. 61, 5619-5429.
70. Näthke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., and Nelson, W. J. (1996). The adenomatous polyposis-coli tumor-suppressor protein localizes to plasma-membrane sites involved in active cell-migration. J. Cell Biol. 134, 165-179.
71. Wong, M. H., Hermiston, M. L., Syder, A. J., and Gordon, J. I. (1996). Forced expression of the tumor-suppressor adenomatosis polyposis-coli protein induces disordered cell-migration in the intestinal epithelium. Proc. Natl. Acad. Sci. USA 93, 9588-9593.
72. Monga, S. P., Mars, W. M., Pediaditakis, P., Bell, A., Mule, K., Bowen, W. C., Wang, X., Zarnegar, R., and Michalopoulos, G. K. (2002). Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res. 62, 2064-2071.
73. Inui, M., Nishi, N., Yasumoto, A., Takenaka, I., Miyanaka, H., Matsumoto, K., Nakamura, T., and Wada, F. (1996). Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer. Urol. Res. 24, 55-60.
74. Karihaloo, A., O'Rourke, D. A., Nickel, C., Spokes, K., and Cantley, L. G. (2001). Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J. Biol. Chem. 276, 9166-9173.
75. Lengyel, E., Stepp, E., Gum, R., and Boyd, D. (1995). Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J. Biol. Chem. 270, 23007-23012.
76. Basbaum, C. B., and Werb, Z. (1996). Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8, 731-738.
77. Valles, A. M., Tucker, G. C., Thiery, J. P., and Boyer, B. (1990). Alternative patterns of mitogenesis and cell scattering induced by acidic FGF as a function of cell density in a rat bladder carcinoma cell line. Cell Regul. 1, 975-988.
78. Longo, F. M., Martignetti, J. A., Le Beau, J. M., Zhang, J. S., Barnes, J. P., and Brosius, J. (1993). Leukocyte common antigen-related receptor-linked tyrosine phosphatase: Regulation of mRNA expression. J. Biol. Chem. 268, 26503-26511.
79. Gebbink, M. F. B. G., Zondag, G. C. M., Konigstein, G. M., Feiken, E., Wubbolts, R. W., and Moolenaar, W. H. (1995). Cell surface expression of receptor protein tyrosine phosphatase RPTP3 is regulated by cell-cell contact. J. Cell Biol. 131, 251-260.
80. Rappolee, D. A., Mark, D., Banda, M. J., and Werb, Z. (1988). Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping. Science 241, 708-712.
81. Werner, S., Peters, K. G., Longaker, M. T., Fuller-Pace, F., Banda, M. J., and Williams, L. T. (1992). Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA 89, 6896-6900.
82. Zhang, F., White, R. L., and Neufeld, K. L. (2001). Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol. Cell. Biol. 21, 8143-8156.
83. Mariadason, J. M., Bordonaro, M., Aslam, F., Shi, L., Kuraguchi, M., Velcich, A., and Augenlicht, L. H. (2001). Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res. 61, 3465-3471.
84. Naishiro, Y., Yamada, T., Takaoka, A. S., Hayashi, R., Hasegawa, F., Imai, K., and Hirohashi, S. (2001). Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res. 61, 2751-2758.
85. Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., Knuechel, R., and Kirchner, T. (2001). Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 98, 10356-10361.
86. Orford, K., Orford, C. C., and Byers, S. W. (1999). Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol. 146, 855-868.
87. Philip, S., Bulbule, A., and Kundu, G. C. (2001). Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 276, 44926-44935.
88. Jouanneau, J., Plouet, J., Moens, G., and Thiery, J. P. (1997). FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo. Oncogene 14, 671-676.
89. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
90. Porter, A. C., and Vaillancourt, R. R. (1998). Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17, 1343-1352.
91. Comoglio, P. M., and Boccaccio, C. (2001). Scatter factors and invasive growth. Semin. Cancer Biol. 11, 153-165.
92. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. (1987). Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235, 177-182.
93. Seymour, L. K. (2001). Epidermal growth factor receptor as a target: Recent developments in the search for effective new anti-cancer agents. Curr. Drug Targets 2, 117-133.
94. Longati, P., Comoglio, P. M., and Bardelli, A. (2001). Receptor tyrosine kinases as therapeutic targets: The model of the MET oncogene. Curr. Drug Targets 2, 41-55.
95. Danikovitch-Miagkova, A., Miagkov, A., Skeel, A., Nakaigawa, N., Zbar, B., and Leonard, E. J. (2001). Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol. Cell. Biol. 21, 5857-5868.